The FDA recently selected the first participant for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. The news release from July 22, 2026, identified Dexcom, Inc. as the first manufacturer selected for the TEMPO Pilot. Manufacturers selected for TEMPO intend to offer a device for use in providing care covered by CMS’s...Read More
Upcoming Public Courses
No public courses are planned at this time.
If you would like to discuss a private, onsite course, please fill out the form below.
